Avistone Pharmaceuticals Funding: $340M Raised, Series A
Avistone Pharmaceuticals is based in Beijing, China. It has raised $340M in total funding. Latest round: Series A.
Avistone Pharmaceuticals funding overview
Avistone Pharmaceuticals is based in Beijing, China. Avistone Pharmaceuticals has raised $340M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in December 2021. The round record for Avistone Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Vivo Capital, Bain Capital, Primavera Capital. 3 distinct backers are named across the disclosed rounds.
Avistone Pharmaceuticals at a glance
Total raised
$340M
Latest round
Series A
Latest round date
December 2021
Headquarters
Beijing, China
Notable investors
Vivo Capital, Bain Capital, Primavera Capital
Frequently asked about Avistone Pharmaceuticals funding
How much has Avistone Pharmaceuticals raised?
Avistone Pharmaceuticals has raised $340M in total disclosed funding across the rounds on record.
Who has invested in Avistone Pharmaceuticals?
Vivo Capital, Bain Capital, Primavera Capital are named among the investors backing Avistone Pharmaceuticals.
What was the latest Avistone Pharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in December 2021.
Where is Avistone Pharmaceuticals based?
Avistone Pharmaceuticals is based in Beijing, China.
When did Avistone Pharmaceuticals last raise?
The last disclosed Avistone Pharmaceuticals round closed in December 2021 at Series A.
Round data for Avistone Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Beijing and backer lists below.
Companies related to Avistone Pharmaceuticals (36)
